Brazil National Agency for Supplementary Health, known as ANS, approved an authorization request for
- Conclusion of Hapvida and Intermedica business combination operation is subject to review and approval by Brazil antitrust regulator Cade
- NOTE:
Brazil’s Hapvida and Intermedica to Merge Into Health-Care Giant
Original Story:
To contact the translator on this story:
Reporter on the original story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
